Clinical Trials Logo
  1. Home
  2. Influenza A Virus, H1N1 Subtype
  3. NCT01053533

A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza — 200907001-2A  

Influenza A Virus, H1N1 Subtype Clinical Trial

Clinical Trial Summary

The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe pandemic H1N1 influenza.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01053533
Study type Interventional
Source Beijing Ditan Hospital
Contact
Status Recruiting
Phase N/A
Start date January 2010
Completion date April 2010
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01063608 - Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. Phase 4
Completed NCT00989404 - Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days Phase 1
Completed NCT01016548 - Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy Phase 3
Completed NCT01053143 - Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India Phase 3
Completed NCT00973895 - VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old Phase 1